Remission of Cushing’s disease associated with higher risk of developing autoimmune disease

Credit: Pixabay/CC0 Public Domain A study of more than 250 persons undergoing surgical therapy for Cushing’s disease (CD) or nonfunctioning pituitary adenomas (NFPAs) found that patients who achieved remission of…

Trial data underpins FDA approval of omalizumab for food allergy

Credit: Unsplash/CC0 Public Domain Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of…

A promising avenue for more effective immunotherapies

Graphical abstract. Credit: Cell Reports (2024). DOI: 10.1016/j.celrep.2024.11377 A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients…

Immunotherapy post-surgery found to improve overall survival for kidney cancer

Credit: Pixabay/CC0 Public Domain For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in…

Common cold or COVID-19? Some T cells are ready to combat both

LJI Research Instructor Annie Elong Ngono (left) and LJI Postdoctoral Fellow Rúbens Alves, Ph.D., served as co-first authors of the new SARS-CoV-2 study. Credit: Matthew Ellenbogen, LJI Creative Producer Scientists…

What if every germ hit you at the exact same time? An immunologist explains

Curious Kids is a series for children of all ages. If you have a question you’d like an expert to answer, send it to curiouskidsus@theconversation.com. What would happen if all…

Biomedical engineers unveil the dynamics of maternal immune responses

Mechanistic model captures IgG subclass-specific transfer dynamics. Credit: PLOS Computational Biology (2023). DOI: 10.1371/journal.pcbi.1011109 Sepideh Dolatshahi, an assistant professor of biomedical engineering at the University of Virginia, is spearheading an…

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Cancer cell during cell division. Credit: National Institutes of Health Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of…

Cell therapy appears safe and effective for lymphoma in remission

Credit: University of Miami Leonard M. Miller School of Medicine A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests…

Research shows that being overweight hampers the body’s immune response to SARS-CoV-2

Credit: Unsplash/CC0 Public Domain University of Queensland-led research shows being overweight can impair the body’s antibody response to SARS-CoV-2 infection but not to the protection offered by vaccination. Research lead,…